In July 2000, the American Academy of Pediatrics (AAP) and the CDC jointly recommended childhood pneumococcal immunization, since pneumococcal infections are the most common invasive bacterial infections in children in the United States. "The pneumococcal conjugate vaccine, PCV13 or Prevnar 13, is currently recommended for all children younger than 5 years of age, all adults 65 years or older, and persons 6 through 64 years of age with certain medical conditions," according to the 2014 AAP/CDC guidelines.

The article cited AMA's "Global Pneumococcal Vaccine Market Study" explored CAGR of 2.1%. According to the report, The Rising Awareness among the Patients about Pneumococcal Vaccines and Its Benefits Has Boosted the Pneumococcal Vaccines Market is one of the primary growth factors for the market. The Developing Countries Are Progressively Investing in the Manufacturing of Vaccines That is leading to an Expansion in the Global Pneumococcal Vaccines Market is also expected to contribute significantly to the Pneumococcal Vaccine market growth. Overall, Medical care applications of Pneumococcal Vaccine, and the growing awareness of them, is what makes this segment of the industry important to its overall growth. The Sector Type, such as Public, is boosting the Pneumococcal Vaccine market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.The Vaccine Antigens, such as 7 - Valent Vaccine, is boosting the Pneumococcal Vaccine market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.The Distribution Channel, such as Non-Governmental Organizations, is boosting the Pneumococcal Vaccine market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.The Vaccine Type, such as Synflorix, is boosting the Pneumococcal Vaccine market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.The End User, such as Adults Above 65 Years, is boosting the Pneumococcal Vaccine market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.

AMA’s Analyst on the Global Pneumococcal Vaccine market identified that the demand is rising in many different parts of the world as "Continuous Research and Development Activities and Great Initiatives Taken By the Governments Would Provide New Opportunities for the Market ".

The report provides an in-depth analysis and forecast about the industry covering the following key features:
o Industry outlook including current and future market trends, drivers, restraints, and emerging technologies
o Analyses the Global Pneumococcal Vaccine market according to Type, Application, and regions
o Analyzes the top 10 players in terms of market reach, business strategy, and business focus
o Provides stakeholders’ insights and key drivers & trends of the market

**The market is valued based on weighted average selling price (WASP) and includes any applicable taxes on manufacturers. All currency conversions used in the creation of this report have been calculated using constant annual average 2018 currency rates.

Market Size Estimation
In market engineering method, both top-down and bottom-up approaches have been used, along with various data triangulation process, to predict and validate the market size of the Pneumococcal Vaccine market and other related sub-markets covered in the study.

o Key & emerging players in the market have been observed through secondary research.
o The industry’s supply chain and overall market size, in terms of value, have been derived through primary and secondary research processes.
o All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Have a look at complete Table of Content: Global Pneumococcal Vaccine Market Study

Data Triangulation
The overall Pneumococcal Vaccine market size is calculated using market estimation process, the Pneumococcal Vaccine market was further split into various segments and sub-segments. To complete the overall market engineering and arriving at the exact statistics for all segments and sub-segments, the market breakdown and data triangulation procedures have been utilized, wherever applicable. The data have been triangulated by studying various influencing factors and trends identified from both demand and supply sides of various applications involved in the study. Along with this, the Global Pneumococcal Vaccine market size has been validated using both top-down and bottom-up approaches.